Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Aspira Women's Health stock price, quote, forecast and news

AWH
US04537Y1091
A2P6V3

Price

1.07
Today +/-
+0.01
Today %
+0.92 %
P

Aspira Women's Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Aspira Women's Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Aspira Women's Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Aspira Women's Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Aspira Women's Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Aspira Women's Health Stock Price History

DateAspira Women's Health Price
8/23/20241.07 undefined
8/22/20241.06 undefined
8/21/20241.07 undefined
8/20/20241.01 undefined
8/19/20241.02 undefined
8/16/20241.06 undefined
8/15/20241.10 undefined
8/14/20241.13 undefined
8/13/20241.09 undefined
8/12/20241.13 undefined
8/9/20241.14 undefined
8/8/20241.17 undefined
8/7/20241.16 undefined
8/6/20241.14 undefined
8/5/20241.10 undefined
8/2/20241.18 undefined
8/1/20241.31 undefined
7/31/20241.30 undefined
7/30/20241.36 undefined
7/29/20241.48 undefined

Aspira Women's Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Aspira Women's Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aspira Women's Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aspira Women's Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Aspira Women's Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Aspira Women's Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Aspira Women's Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aspira Women's Health’s growth potential.

Aspira Women's Health Revenue, EBIT and net profit per share

DateAspira Women's Health RevenueAspira Women's Health EBITAspira Women's Health Net Income
2029e123.52 M undefined0 undefined0 undefined
2028e102.92 M undefined-15.86 M undefined0 undefined
2027e82.32 M undefined-18.48 M undefined0 undefined
2026e38.47 M undefined-7.27 M undefined-3.27 M undefined
2025e22.06 M undefined-13.22 M undefined-8.24 M undefined
2024e10.58 M undefined-17.75 M undefined-15.84 M undefined
20239.15 M undefined-18.85 M undefined-16.69 M undefined
20228.18 M undefined-32.72 M undefined-27.17 M undefined
20216.81 M undefined-32.6 M undefined-31.66 M undefined
20204.65 M undefined-17.98 M undefined-17.91 M undefined
20194.54 M undefined-15.28 M undefined-15.24 M undefined
20183.05 M undefined-11.33 M undefined-11.37 M undefined
20173.12 M undefined-10.44 M undefined-11.44 M undefined
20162.64 M undefined-14.95 M undefined-14.97 M undefined
20152.18 M undefined-19.25 M undefined-19.12 M undefined
20142.52 M undefined-19.21 M undefined-19.21 M undefined
20132.57 M undefined-8.86 M undefined-8.82 M undefined
20122.09 M undefined-9.42 M undefined-7.15 M undefined
20111.92 M undefined-17.64 M undefined-17.79 M undefined
20101.18 M undefined-14.6 M undefined-19.03 M undefined
20090 undefined-5.36 M undefined-22.05 M undefined
2008120,000 undefined-14.52 M undefined-18.33 M undefined
200740,000 undefined-21.23 M undefined-21.28 M undefined
200618.22 M undefined-25.83 M undefined-22.07 M undefined
200527.25 M undefined-32.06 M undefined-35.43 M undefined
200440.18 M undefined-34.32 M undefined-19.84 M undefined

Aspira Women's Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0012581929434027180001122222334468910223882102123
---100.00150.0060.00137.5052.6348.28-6.98-32.50-33.33-----100.00----50.00-33.33-50.0033.3312.5011.11120.0072.73115.7924.3920.59
---50.0060.0062.5063.1665.5265.1262.5048.1544.44---100.00100.0050.00100.0050.00----25.0025.0050.0050.0055.56------
0001351219282513800011121000011345000000
-2-3-5-7-7-22-28-32-31-34-32-25-21-14-5-14-17-9-8-19-19-14-10-11-15-17-32-32-18-17-13-7-18-150
---500.00-350.00-140.00-275.00-147.37-110.34-72.09-85.00-118.52-138.89----1,400.00-1,700.00-450.00-400.00-950.00-950.00-700.00-333.33-366.67-375.00-425.00-533.33-400.00-200.00-170.00-59.09-18.42-21.95-14.71-
-2-3-6-8-8-47-25-29-36-19-35-22-21-18-22-19-17-7-8-19-19-14-11-11-15-17-31-27-16-15-8-3000
-50.00100.0033.33-487.50-46.8116.0024.14-47.2284.21-37.14-4.55-14.2922.22-13.64-10.53-58.8214.29137.50--26.32-21.43-36.3613.3382.35-12.90-40.74-6.25-46.67-62.50---
00.010.020.030.040.080.180.180.190.190.220.240.320.430.440.690.9511.42.413.143.483.84.675.776.727.417.779.23000000
-----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Aspira Women's Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Aspira Women's Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (k)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
72.8107.669.639.947.337.62817.716.52.53.422.922.5829.52318.65.25.59.411.716.637.213.32.6
1.1135.713.314.710.85.800000.10.10.10.40.20.10.30.20.80.90.911.21.46
00003001001000000000000000000000
0.70.71.33.96.98.36.95.60000000000.10.10.10.1000.20.30.23
0.20.312.22.82.91.81.72.31.10.30.50.80.30.30.40.50.60.50.50.60.81.11.61.41
94.8112.981.463.273.357.241.12017.62.83.923.822.98.430.323.719.46.16.310.913.418.64016.25.28
0.80.94.710.213.415.99.37.32.31.90.60.20.20.20.10.40.51.51.91.20.60.410.80.70.69
00.207.52.700003.90.30.500000000000000
30030030040020020000000000000000000000
00000732.4000000000000000000
1.10.70.46.77.52.92.50.1000000000000000000
000.60.70.72.82.21.90.70.60.10000000.10000.100.30.40.29
2.22.1625.524.528.81711.736.410.70.20.20.10.40.51.61.91.20.60.511.11.10.98
11.26.9118.9106.987.7102.174.252.823243.84.62423.18.530.724.22187.511.513.919.641.117.36.26
24.325.30000000000000000.10.10.10.10.10.10.10.10.01
5.99.7174.4174173.4185186.8202.5208227.9228.6252.2303.3326.8328.1359370.7388.1389.3399.4414430.8449.7501.8505.5515.93
-20.5-28.6-48.9-74.7-103.8-140.5-160.4-195.8-217.9-239.1-257.5-279.5-298.5-316.3-323.4-332.3-351.5-370.6-385.6-396.1-406.9-422.2-440.1-471.7-498.9-518.3
-1.3-3.7-12.4-6.1-1.33.40.3-0.2-0.1-0.2-0.2-0.2-0.2-0.2000000000000
0000000000010000000000000000
8.42.7113.193.268.347.926.76.5-10-11.4-29.1-27.44.610.34.726.719.217.63.83.47.28.79.730.26.7-2.37
0.80.80.93.25.65.13.43.22.431.72.211.30.50.51.110.90.711.21.11.50.91.26
0.70.92.94.65.59.57.56.34.63.62.41.93.12.61.11.32.22.21.51.71.82.63.65.43.73.02
0.40.30.723.95.85.54.10000.410.60.50.60.50.200000000
00.80000000000571.11.11.100.20.20.20.20.60.80.80.67
0.50.50.40.50.510.90.402.52.5000000000000.60.20.40.17
2.43.34.910.315.521.417.31479.16.64.510.111.53.23.54.93.42.62.6345.97.95.85.12
0.40.50.42.12.330.928.531.125.526.226.410700000.11.71.51.31.13.52.72.31.43
00000000000000000000000000
00.30.41.11.41.81.91.20.40.3017.42.31.30.80.30000000.40.32.62.08
0.40.80.83.23.732.730.432.325.926.526.427.49.31.30.80.300.11.71.51.31.13.934.93.51
2.84.15.713.519.254.147.746.332.935.63331.919.412.843.84.93.54.34.14.35.19.810.910.78.63
11.26.8118.8106.787.510274.452.822.924.23.94.52423.18.730.524.121.18.17.511.513.819.541.117.46.26
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Aspira Women's Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Aspira Women's Health's financial health and stability.

Assets

Aspira Women's Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Aspira Women's Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Aspira Women's Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Aspira Women's Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-6-8-8-20-25-29-36-19-35-22-21-18-22-19-17-7-8-19-19-14-10-11-15-17-31-27
01012466541000000000000000
00000000000000000000000000
0-10-12-52-4300-14-30-2010000011-2
03110627-143-20313120000111112-2
00000001,00001,0001,0001,00001,000000000000000
00000002000000000000000000
-4-4-5-9-14-27-20-32-22-20-20-15-3-20-15-10-8-16-18-13-8-9-12-14-27-32
000-4-4-4-6-4-20000000000-1000000
000-4-447-433-316-1110000100-1-1000000
0000-4011238017-101000010000000000
00000000000000000000000000
120-10-431-11-6200-2-5-500-11000200
29112000111531803422003010160813156489
41111190-330017-421044015-530101518131520488
000000-100000000000000001000
00000000000000000000000000
06-4104-59-2372-9-8-10-50190-1421-6-4-13032420-23
-5.06-5.12-5.68-14.56-18.71-31.62-27-37.03-25.74-21.03-21.13-15.53-3.11-21.12-15.68-10.41-8.54-17.07-18.65-15.22-8.19-9.48-13.1-15.22-27.58-32.42
00000000000000000000000000

Aspira Women's Health stock margins

The Aspira Women's Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aspira Women's Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aspira Women's Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Aspira Women's Health's sales revenue. A higher gross margin percentage indicates that the Aspira Women's Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Aspira Women's Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Aspira Women's Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aspira Women's Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aspira Women's Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aspira Women's Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Aspira Women's Health Margin History

Aspira Women's Health Gross marginAspira Women's Health Profit marginAspira Women's Health EBIT marginAspira Women's Health Profit margin
2029e57.48 %0 %0 %
2028e57.48 %-15.41 %0 %
2027e57.48 %-22.45 %0 %
2026e57.48 %-18.9 %-8.5 %
2025e57.48 %-59.95 %-37.34 %
2024e57.48 %-167.75 %-149.74 %
202357.48 %-205.94 %-182.32 %
202252.81 %-400 %-332.15 %
202144.93 %-478.71 %-464.9 %
202026.67 %-386.67 %-385.16 %
201926.43 %-336.56 %-335.68 %
2018-2.95 %-371.48 %-372.79 %
20176.73 %-334.62 %-366.67 %
2016-2.27 %-566.29 %-567.05 %
2015-5.96 %-883.03 %-877.06 %
201451.19 %-762.3 %-762.3 %
201393.39 %-344.75 %-343.19 %
201293.78 %-450.72 %-342.11 %
201193.23 %-918.75 %-926.56 %
201092.37 %-1,237.29 %-1,612.71 %
200957.48 %0 %0 %
200883.33 %-12,100 %-15,275 %
200750 %-53,075 %-53,200 %
200648.74 %-141.77 %-121.13 %
200549.72 %-117.65 %-130.02 %
200462.49 %-85.42 %-49.38 %

Aspira Women's Health Stock Sales Revenue, EBIT, Earnings per Share

The Aspira Women's Health earnings per share therefore indicates how much revenue Aspira Women's Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aspira Women's Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aspira Women's Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aspira Women's Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aspira Women's Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aspira Women's Health Revenue, EBIT and net profit per share

DateAspira Women's Health Sales per ShareAspira Women's Health EBIT per shareAspira Women's Health Earnings per Share
2029e9.92 undefined0 undefined0 undefined
2028e8.27 undefined0 undefined0 undefined
2027e6.61 undefined0 undefined0 undefined
2026e3.09 undefined0 undefined-0.26 undefined
2025e1.77 undefined0 undefined-0.66 undefined
2024e0.85 undefined0 undefined-1.27 undefined
20230.99 undefined-2.04 undefined-1.81 undefined
20221.05 undefined-4.21 undefined-3.5 undefined
20210.92 undefined-4.4 undefined-4.27 undefined
20200.69 undefined-2.68 undefined-2.67 undefined
20190.79 undefined-2.65 undefined-2.64 undefined
20180.65 undefined-2.43 undefined-2.43 undefined
20170.82 undefined-2.75 undefined-3.01 undefined
20160.76 undefined-4.3 undefined-4.3 undefined
20150.69 undefined-6.13 undefined-6.09 undefined
20141.05 undefined-7.97 undefined-7.97 undefined
20131.84 undefined-6.33 undefined-6.3 undefined
20122.09 undefined-9.42 undefined-7.15 undefined
20112.02 undefined-18.57 undefined-18.73 undefined
20101.71 undefined-21.16 undefined-27.58 undefined
20090 undefined-12.18 undefined-50.11 undefined
20080.28 undefined-33.77 undefined-42.63 undefined
20070.13 undefined-66.34 undefined-66.5 undefined
200675.92 undefined-107.63 undefined-91.96 undefined
2005123.86 undefined-145.73 undefined-161.05 undefined
2004211.47 undefined-180.63 undefined-104.42 undefined

Aspira Women's Health business model

Aspira Women's Health Inc is a leading company in the field of women's health, specializing in innovative products and services to support women in the detection and treatment of gynecological diseases. Aspira Women's Health is one of the most popular companies on Eulerpool.com.

Aspira Women's Health SWOT Analysis

Strengths

Aspira Women's Health Inc has several strengths that contribute to its success in the market. These strengths include:

  • Strong and experienced management team
  • Advanced technology and innovative products
  • Strong brand reputation and recognition
  • Wide range of healthcare solutions for women
  • Established distribution network and partnerships
  • Strong financial position and steady revenue growth

Weaknesses

Despite its strengths, Aspira Women's Health Inc also faces a few key weaknesses that could potentially hinder its growth and performance. These weaknesses include:

  • Dependency on a limited number of key suppliers
  • Relatively high production costs affecting profitability
  • Limited global presence compared to some competitors
  • Subject to regulatory risks and compliance challenges
  • Potential lack of diversification in product portfolio

Opportunities

There are several opportunities that Aspira Women's Health Inc can capitalize on to further expand its market presence and improve its performance. These opportunities include:

  • Growing demand for women's healthcare solutions globally
  • Expanding into new geographical markets and untapped segments
  • Developing strategic partnerships and collaborations
  • Investing in research and development for new product innovations
  • Increasing awareness and education about women's health

Threats

Aspira Women's Health Inc should also be cautious of potential threats that could impact its business operations and market position. These threats include:

  • Intense competition from existing and emerging players
  • Changes in healthcare regulations and policies
  • Economic downturn or instability affecting consumer spending
  • Rapid technological advancements and potential obsolescence
  • Potential legal and liability issues

Aspira Women's Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Aspira Women's Health historical P/E ratio, EBIT, and P/S ratio.

Aspira Women's Health shares outstanding

The number of shares was Aspira Women's Health in 2023 — This indicates how many shares 9.233 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aspira Women's Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aspira Women's Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aspira Women's Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aspira Women's Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aspira Women's Health Stock splits

In Aspira Women's Health's history, there have been no stock splits.

Aspira Women's Health dividend history and estimates

In 2023, Aspira Women's Health paid a dividend amounting to 0 USD. Dividend means that Aspira Women's Health distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Aspira Women's Health provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Aspira Women's Health’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Aspira Women's Health's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Aspira Women's Health Dividend History

DateAspira Women's Health Dividend
20160.52 undefined
20150.75 undefined
20141.18 undefined
20131.5 undefined
20121.5 undefined
20111.13 undefined
20100.8 undefined
20090.74 undefined
20080.72 undefined
20070.48 undefined
20060.15 undefined

Aspira Women's Health dividend payout ratio

In 2023, Aspira Women's Health had a payout ratio of 0%. The payout ratio indicates the percentage of the company's profits that Aspira Women's Health distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Aspira Women's Health represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Aspira Women's Health could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Aspira Women's Health's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Aspira Women's Health Payout Ratio History

DateAspira Women's Health Payout ratio
2029e0 %
2028e0 %
2027e0 %
2026e0 %
2025e0 %
2024e0 %
20230 %
20220 %
20210 %
20200 %
20190 %
20180 %
20170 %
2016-12.09 %
2015-12.25 %
2014-14.71 %
2013-23.73 %
2012-21.01 %
2011-6.01 %
2010-2.9 %
2009-1.48 %
2008-1.69 %
2007-0.72 %
2006-0.16 %
20050 %
20040 %
Unfortunately, there are currently no price targets and forecasts available for Aspira Women's Health.

Aspira Women's Health latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.31 -0.28  (9.12 %)2024 Q2
3/31/2024-0.34 -0.39  (-16.14 %)2024 Q1
12/31/2023-0.45 -0.3  (33.63 %)2023 Q4
9/30/2023-0.51 -0.48  (6.36 %)2023 Q3
6/30/2023-0.56 -0.28  (49.6 %)2023 Q2
3/31/2023-0.76 -0.73  (3.63 %)2023 Q1
12/31/2022-0.98 -0.6  (39.07 %)2022 Q4
9/30/2022-0.98 -1.2  (-21.85 %)2022 Q3
6/30/2022-1.06 -1.05  (0.99 %)2022 Q2
3/31/2022-1.21 -1.2  (0.99 %)2022 Q1
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Aspira Women's Health stock

Eulerpool World ESG Rating (EESG©)

35/ 100

🌱 Environment

37

👫 Social

39

🏛️ Governance

29

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Aspira Women's Health list of shareholders

%
Name
Stocks
Change
Date
4.93 % Schuler (Henri George)613,85203/18/2024
4.37 % Schultz (Eric Adam)543,99801/14/2024
3.03 % Seamark Capital, LP377,8187,22012/31/2022
15.13 % Schuler (Jack W)1,883,656157,9817/24/2023
10.53 % Drysdale (Robert H)1,310,531838,5653/18/2024
1.57 % The Vanguard Group, Inc.196,00713,16212/31/2023
1.44 % B. Riley Wealth Advisors, Inc.179,37153,99712/31/2023
0.55 % Harrington David T68,3336,33312/31/2022
0.50 % BlackRock Institutional Trust Company, N.A.62,645-40312/31/2023
0.49 % Sandford (Nicole)61,10303/18/2024
1
2
3
4
5
...
10

Most common questions regarding Aspira Women's Health

What values and corporate philosophy does Aspira Women's Health represent?

Aspira Women's Health Inc embodies values of compassion, innovation, and dedication to improving women's healthcare. With a strong corporate philosophy aimed at empowering women and providing them with accurate diagnostic information, Aspira Women's Health Inc is committed to offering personalized and reliable solutions for early detection of ovarian cancer. Through cutting-edge technologies and a patient-centered approach, the company strives to enhance the lives of women and promote better health outcomes. Aspira Women's Health Inc aims to revolutionize the field of women's health by delivering high-quality diagnostic products and services that prioritize accuracy and patient well-being.

In which countries and regions is Aspira Women's Health primarily present?

Aspira Women's Health Inc is primarily present in the United States of America.

What significant milestones has the company Aspira Women's Health achieved?

Aspira Women's Health Inc has achieved significant milestones since its inception. The company has successfully developed and commercialized innovative diagnostic tools and services to improve women's healthcare. Notably, Aspira Women's Health Inc has received FDA clearance for its flagship product, OVA1®, a non-invasive ovarian cancer detection test. Additionally, the company has expanded its test offerings with the launch of Aspira GenetiXSM, a genetic cancer predisposition panel. Aspira Women's Health Inc continues to make strides in advancing early detection and personalized medicine for better women's health outcomes.

What is the history and background of the company Aspira Women's Health?

Aspira Women's Health Inc is a leading women's health company specializing in the development and commercialization of advanced screening tools for ovarian cancer. Founded in 2008, the company has been at the forefront of revolutionizing early detection and management of gynecologic diseases. Aspira's innovative products, including OVA1 and Overa, provide healthcare professionals with enhanced diagnostic capabilities, allowing for earlier intervention and improved patient outcomes. With a commitment to improving women's health, Aspira Women's Health Inc continues to research, develop, and deliver cutting-edge solutions for gynecologic diseases, making a significant impact in the field of women's healthcare worldwide.

Who are the main competitors of Aspira Women's Health in the market?

The main competitors of Aspira Women's Health Inc in the market are companies like Myriad Genetics, Inc., Roche Diagnostics, and Hologic, Inc.

In which industries is Aspira Women's Health primarily active?

Aspira Women's Health Inc is primarily active in the healthcare industry.

What is the business model of Aspira Women's Health?

Aspira Women's Health Inc. operates as a specialized diagnostic company focused on women's health. The company's business model revolves around offering diagnostic testing services and tools to aid in the early detection and management of gynecologic conditions, particularly ovarian cancer. By leveraging advanced biomarker-based technologies and partnerships with healthcare professionals, Aspira Women's Health aims to provide accurate and timely diagnostic solutions to improve patient outcomes. With a commitment to advancing women's health, the company utilizes innovative approaches and ongoing research to enhance the detection and treatment of gynecologic diseases. Aspira Women's Health Inc. is dedicated to empowering women through accessible and effective diagnostic solutions.

What is the P/E ratio of Aspira Women's Health 2024?

The Aspira Women's Health P/E ratio is -0.62.

What is the P/S ratio of Aspira Women's Health 2024?

The Aspira Women's Health P/S ratio is 0.93.

What is the AlleAktien quality score of Aspira Women's Health?

The AlleAktien quality score for Aspira Women's Health is 7/10.

What is the revenue of Aspira Women's Health 2024?

The expected Aspira Women's Health revenue is 10.58 M USD.

How high is the profit of Aspira Women's Health 2024?

The expected Aspira Women's Health profit is -15.84 M USD.

What is the business model of Aspira Women's Health

Aspira Women's Health Inc. is an innovative company in the healthcare industry that focuses on the development and marketing of diagnostic and therapeutic solutions for women. The company was founded in 2017 through the merger of Aspira Labs and Vermillion and has since taken a leading role in the industry. Aspira Women's Health offers a variety of products and services aimed at improving women's health and providing better diagnostic options. One of the company's main areas is identifying risk factors for early detection of ovarian cancer. For this purpose, the company has developed the OVA1 test, which measures a combination of five marker proteins to help identify the risk of ovarian cancer. The goal is to enable early detection of ovarian cancer to improve treatment and cure chances. Other products from Aspira Women's Health include the Aspira Sampling Brush Kit, which allows patients to collect cervical cells through a simple and painless vaginal swab. The kit enables quick and reliable analysis of cell samples and thus the prevention and treatment of cervical cancer. Another important area of the company is medical research and development. Aspira Women's Health continuously invests in innovative technologies and R&D programs to explore and develop new diagnostic and therapeutic options. As a healthcare company, Aspira Women's Health has a broad network of partners and customers, including doctors, hospitals, research institutions, and pharmaceutical manufacturers. The company builds on these relationships to market its solutions effectively and expand its business activities. Aspira Women's Health's business model is designed for sustainable growth and long-term success. The company has developed clear financial goals and strategies that consider both operational and clinical engagement. The company works to continuously improve and expand its services and products to meet the needs of its customers and partners. In summary, Aspira Women's Health is a leading company in the field of women's health, offering innovative solutions for the prevention, detection, and treatment of cancer and other diseases. With a strong market position, a wide portfolio of products and services, and continuous investment in R&D, the company is working hard to improve the lives of women worldwide.

What is the Aspira Women's Health dividend?

Aspira Women's Health pays a dividend of 0 USD distributed over payouts per year.

How often does Aspira Women's Health pay dividends?

The dividend cannot currently be calculated for Aspira Women's Health or the company does not pay out a dividend.

What is the Aspira Women's Health ISIN?

The ISIN of Aspira Women's Health is US04537Y1091.

What is the Aspira Women's Health WKN?

The WKN of Aspira Women's Health is A2P6V3.

What is the Aspira Women's Health ticker?

The ticker of Aspira Women's Health is AWH.

How much dividend does Aspira Women's Health pay?

Over the past 12 months, Aspira Women's Health paid a dividend of 0.52 USD . This corresponds to a dividend yield of about 48.61 %. For the coming 12 months, Aspira Women's Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Aspira Women's Health?

The current dividend yield of Aspira Women's Health is 48.61 %.

When does Aspira Women's Health pay dividends?

Aspira Women's Health pays a quarterly dividend. This is distributed in the months of July, October, April, July.

How secure is the dividend of Aspira Women's Health?

Aspira Women's Health paid dividends every year for the past 0 years.

What is the dividend of Aspira Women's Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aspira Women's Health located?

Aspira Women's Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aspira Women's Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspira Women's Health from 6/30/2016 amounting to 0.26 USD, you needed to have the stock in your portfolio before the ex-date on 6/17/2016.

When did Aspira Women's Health pay the last dividend?

The last dividend was paid out on 6/30/2016.

What was the dividend of Aspira Women's Health in the year 2023?

In the year 2023, Aspira Women's Health distributed 0 USD as dividends.

In which currency does Aspira Women's Health pay out the dividend?

The dividends of Aspira Women's Health are distributed in USD.

All fundamentals about Aspira Women's Health

Our stock analysis for Aspira Women's Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspira Women's Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.